AIMCA
EVLO

Alberta Investment Management Corp (AIMCo)’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,000
Closed -$243K – 1377
2021
Q4 		$243K Buy
+2,000
New +$338K ﹤0.01% 937
2021
Q3 		– Sell
-2,000
Closed -$550K – 1049
2021
Q2 		$550K Buy
+2,000
New +$505K ﹤0.01% 851

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s EVLO Position: Q1 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q1 2022, closing a stake of 2,000 shares — an estimated $243K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in EVLO in Q2 2021 and held it in 2 quarters. The position peaked at $550K in Q2 2021. 68 funds tracked by Wall St. Rank hold EVLO as of Q1 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 2,000 Evelo Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $243K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Evelo Biosciences, Inc. Common Stock position peaked at $550K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2022, filed 16 May 2022.